• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Research Briefing on 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID (CAS: 1227515-71-0) and Its Applications in Chemical Biology and Pharmaceutical Research

6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID (CAS: 1227515-71-0) is a pyridine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including kinase inhibitors and other therapeutic agents. Recent studies have explored its utility in drug discovery, particularly in the development of targeted therapies for cancer and inflammatory diseases.

One of the most notable applications of 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID is its role as a building block for the synthesis of small-molecule inhibitors. For instance, it has been used in the development of compounds targeting the JAK-STAT signaling pathway, which is implicated in numerous autoimmune and inflammatory conditions. Researchers have demonstrated that derivatives of this compound exhibit potent inhibitory activity against JAK kinases, making them promising candidates for further preclinical evaluation.

In addition to its role in kinase inhibitor development, 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID has also been investigated for its potential in medicinal chemistry. Recent publications highlight its use in the design of novel prodrugs and drug delivery systems. For example, its carboxylic acid moiety allows for facile conjugation with other pharmacophores, enabling the creation of hybrid molecules with enhanced bioavailability and target specificity. This versatility underscores its value as a scaffold in drug design.

Recent advancements in synthetic methodologies have further expanded the utility of 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID. A 2023 study published in the Journal of Medicinal Chemistry described a streamlined, high-yield synthesis route for this compound, which significantly reduces production costs and improves scalability. This development is particularly relevant for industrial applications, where cost-effective synthesis of intermediates is critical for large-scale drug manufacturing.

Beyond its pharmaceutical applications, 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID has also been explored in chemical biology as a tool for probing enzyme mechanisms. Its structural features make it a suitable substrate for studying the activity of carboxylate-processing enzymes, such as decarboxylases and esterases. Researchers have utilized this compound to gain insights into enzyme-substrate interactions, paving the way for the design of more effective enzyme inhibitors.

In conclusion, 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXYLIC ACID (CAS: 1227515-71-0) represents a versatile and valuable compound in the fields of chemical biology and pharmaceutical research. Its applications range from drug discovery and medicinal chemistry to enzyme mechanism studies, highlighting its broad utility. Ongoing research continues to uncover new opportunities for this compound, reinforcing its importance as a key intermediate in the development of next-generation therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)